Has the Long-Feared Market Correction Arrived?

Stocks have risen for so long that it’s almost puzzling when they fall for any period longer than a couple trading sessions. And that’s what made the last few… Read more

Get Ready For The Next Biotech Boom

There is no doubt that generic drug makers will thrive in the upcoming cost-driven environment of U.S. health-care reform. Generic drugs already make up 70% of prescription sales in… Read more

3 Must-Own Auto Industry Stocks

These stocks are hidden in plain sight and are long term buy and holds. I’ve learned more about the auto industry in the past few years than at any… Read more

How Do I Invest in eCigarettes?

While exploring my new hometown of Boulder, Colorado this weekend it seemed like I was seeing eCigarettes everywhere. At one point a friend turned to me and asked, “Ok, how… Read more

GoPro IPO Goes Big

Thursday wearable camera maker GoPro (Nasdaq: GPRO) made its debut on the Nasdaq stock exchange. The GoPro IPO is one of the more anticipated IPOs of the year, along with the… Read more

Should Investors Lose Sleep Over the Shocking GDP News?

Anytime investors hear the words “worst quarter since the recession,” it makes people sweat on Wall Street. So it was on Tuesday after the Commerce Department reported that the… Read more

For Income Investors, Patience Is A Virtue

Patience is not only a virtue, it’s a necessity to becoming a great investor.  Few investors possess patience, which is why few are great investors. Patience matters even more… Read more

Should Nike Buy Lululemon?

I hadn’t heard it suggested until a colleague of mine hinted at it in an article this week. It was a question I had not yet asked myself. “Should… Read more

Priceline’s OpenTable Deal: Is $2.6 Billion Enough?

Two weeks ago Priceline (Nasdaq: PCLN) announced that it intended to buy OpenTable (Nasdaq: OPEN). The offer of $2.6 billion in cash to buy OpenTable outright represents a premium… Read more

To top